Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Company News
As of June 18, 2025 • 9:31 PM ET
| Date/Time | Source | News Release |
|---|---|---|
| 05/19/2025 07:00 AM EDT | GlobeNewswire | XORTX Announces USD $3 Million Offering |
| 04/30/2025 07:00 AM EDT | GlobeNewswire | XORTX Provides Update on FDA Type B Meeting Request |
| 04/28/2025 07:00 AM EDT | GlobeNewswire | XORTX Announces Grant of European Patent |
| 04/17/2025 07:45 PM EDT | GlobeNewswire | XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency |
| 03/19/2025 07:00 AM EDT | GlobeNewswire | XORTX Announces Update for Discussion with the FDA |
| 02/24/2025 07:00 AM EST | GlobeNewswire | XORTX Commences Gout Program NDA Discussions with the FDA |
| 01/29/2025 07:00 AM EST | GlobeNewswire | XORTX to Present at Microcap Conference |
| 01/17/2025 05:00 PM EST | GlobeNewswire | XORTX Announces Change of Auditor |
| 01/06/2025 07:00 AM EST | GlobeNewswire | XORTX Adds Late Stage Gout Program to Pipeline |
| 12/19/2024 07:00 AM EST | GlobeNewswire | XORTX Strengthens Executive Team |
Additional News
As of June 18, 2025 • 9:31 PM ET
| Date/Time | Source | News Release |
|---|---|---|
| 07/14/2021 07:51 AM EDT | SeekingAlpha | XORTX Therapeutics names Amar Keshri CFO |
| 08/19/2020 09:26 AM EDT | Livemoney | XORTX Therapeutics Moves Toward Phase 3 Trials to Help with an "Orphan" Kidney Disease and COVID-19 Kidney Injuries |
Page
- 1
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.